Announcement

Collapse
No announcement yet.

Geron Trial

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Geron Trial

    If money was the issue of not proceeding with the trials as stated in the following article
    http://cirmresearch.blogspot.com.au/...inal-cord.html
    First patient from Geron spinal cord injury trial speaks up

    Then why don't they ask for financial help from the communitie at large or others pick up the slack or is the trial likely not to prove anything worth while?

    #2
    Originally posted by CAS View Post
    If money was the issue of not proceeding with the trials as stated in the following article
    http://cirmresearch.blogspot.com.au/...inal-cord.html
    First patient from Geron spinal cord injury trial speaks up

    Then why don't they ask for financial help from the communitie at large or others pick up the slack or is the trial likely not to prove anything worth while?
    I wondered that too.... or why CIRM didn't approve a grant to fund the trial...

    Comment


      #3
      Originally posted by rjames View Post
      I wondered that too.... or why CIRM didn't approve a grant to fund the trial...
      But Rick, CIRM had authorized a 25M loan to Geron and had paid out 6.42M. Geron returned the money to CIRM.
      http://www.cirm.ca.gov/PressRelease_2011-11-14
      Maybe you're talking an outright grant that wouldn't need paid back as opposed to the "loan" they'd been given? If that would be the case, I don't think CIRM could have gifted out (grant) taxpayer money to a for profit privately owned biotech company that potentially could have made large profits.

      I think it's set up to "grant" for research and "loan" for biotech "launches" if that makes sense.

      What is the California Institute for Regenerative Medicine (CIRM)?

      The California Institute for Regenerative Medicine (“The Institute” or “CIRM”) is a state agency that was established through the passage of Proposition 71, the California Stem Cell Research and Cures Initiative. The statewide ballot measure, which provided $3 billion in funding for stem cell research at California universities and research institutions, was approved by California voters on November 2, 2004, and called for the establishment of a new state agency to make grants and provide loans for stem cell research, research facilities and other vital research opportunities.

      http://www.cirm.ca.gov/cirm-faq
      Last edited by GRAMMY; 26 Aug 2012, 12:52 AM.
      http://spinalcordresearchandadvocacy.wordpress.com/

      Comment


        #4
        I think that this was a pure Geron business venture when one does not forecast the result /profit as a positive prospect one cuts their losses and bails out.
        For years this venture had been pushed and God knows how many postings on this site but when push came to shove Geron ran away.

        Comment


          #5
          cal stem funds

          talk california stem cells funds into purchasing[ they might sell for cheap] technology and owning the lion share of profits heal people after approval by fda to make money back, we need a deal promoter if its working or can if added study is needed

          Comment


            #6
            Originally posted by GRAMMY View Post
            But Rick, CIRM had authorized a 25M loan to Geron and had paid out 6.42M. Geron returned the money to CIRM.
            http://www.cirm.ca.gov/PressRelease_2011-11-14
            Maybe you're talking an outright grant that wouldn't need paid back as opposed to the "loan" they'd been given? If that would be the case, I don't think CIRM could have gifted out (grant) taxpayer money to a for profit privately owned biotech company that potentially could have made large profits.

            I think it's set up to "grant" for research and "loan" for biotech "launches" if that makes sense.
            Didn't CIRM provide a grant to StemCells Inc. just recently, without any guarantee of any result?

            http://www.msnbc.msn.com/id/48347667#.UDtreaC63TE

            CIRM has got to learn how to structure grant and loan funding. Without milestone payments that affect their livelihood, these people will feel no sense of urgency.

            Comment


              #7
              Originally posted by KofQ View Post
              Didn't CIRM provide a grant to StemCells Inc. just recently, without any guarantee of any result?

              http://www.msnbc.msn.com/id/48347667#.UDtreaC63TE
              Yes, the article states it's pre-clinical work yet.
              http://spinalcordresearchandadvocacy.wordpress.com/

              Comment


                #8
                Originally posted by GRAMMY View Post
                Yes, the article states it's pre-clinical work yet.
                Pre-clinical or not, how is CIRM providing taxpayer funded grants to a for-profit entity, unless they have a stake in any potential profits that may be generated?

                Comment


                  #9
                  http://www.cirm.ca.gov/Grants_Management

                  The pdf's for CIRM grant management can be found here.
                  http://spinalcordresearchandadvocacy.wordpress.com/

                  Comment


                    #10
                    Originally posted by GRAMMY View Post
                    http://www.cirm.ca.gov/Grants_Management

                    The pdf's for CIRM grant management can be found here.
                    Thanks. It looks like CIRM gets a piece of the IP should it lead to a commercial product. I am relieved to see that it's not just some giveaway.

                    9. Sharing of Publication-Related Biomedical Materials
                    CIRM grantees shall share biomedical materials first created with CIRM funding and described in published scientific articles for research purposes in California as specified in the CIRM Intellectual Property and Revenue Sharing Requirements for For-Profit Organizations (Title 17, California Code of Regulations, section 100404). Annual reporting requirements pertaining to CIRM-funded patented inventions and projects, which may extend 15 years beyond the project period, may be found in Title 17, California Code of Regulations, section 100402

                    Comment


                      #11
                      Originally posted by KofQ View Post
                      Thanks.
                      You are welcomed. I posted some of the latest CIRM spinal cord injury studies and awards HERE about 11 days ago if you care to read through them.
                      Last edited by GRAMMY; 28 Aug 2012, 12:44 PM.
                      http://spinalcordresearchandadvocacy.wordpress.com/

                      Comment


                        #12
                        Originally posted by KofQ View Post
                        Thanks. It looks like CIRM gets a piece of the IP should it lead to a commercial product. I am relieved to see that it's not just some giveaway.
                        As much as i would like to see benefits to a non profit organisation from a profit organisation. In this case do's it really matter as the path to cure is what matters.

                        Like i would personally like things to move faster than retarded because i don't want to live in chair anylonger, as i am not getting younger.

                        Comment


                          #13
                          From a report published in the San Francisco Business Times yesterday, it appears that the Geron trial may be revived in the foreseeable future:
                          BioTime acquires stem cell assets from Geron, raises $10 million

                          BioTime Inc. picked up 400 patents and applications plus other intellectual property dealing with human embryonic stem cells from Geron Inc.


                          The deal includes Phase I clinical trials of a treatment for spinal cord injury. The two companies signed a non-binding letter of intent in November outlining the deal.


                          Alameda-based BioTime created a subsidiary, BioTime Acquisition Corp., or BAC, to do the deal, and it also got a $5 million investment in the subsidiary and another $5 million investment in BioTime itself. The money came from "a private investor" that BioTime didn't name.


                          BioTime itself is putting $5 million into BAC, which agreed to pay royalties to Geron on any treatments that come from the work.


                          The unnamed private investor will own about 7 percent of BAC when the deal is done. The investment is contingent upon the closing of the stem cell asset deal with Geron (NASDAQ: GERN), which has some conditions. Geron is investing in BAC, too, and will own about 21.4 percent, leaving BioTime holding 71.6 percent.


                          BioTime leased an office and laboratory space in Menlo Park, where Geron is based, for three years for use by its subsidiary corporation. Thomas Okarma, M.D., will be BAC's CEO and president.


                          Michael West is CEO of BioTime, which is based on Alameda's Bay Farm Island (which ain't actually an island) near the northwest end of Oakland International Airport's main runway.

                          Steven E.F. Brown is web editor at the San Francisco Business Times.
                          God bless the anonymous "private investor"!!!!!!

                          Comment


                            #14
                            This is good news....seems like there are people that believe in the science behind this type of therapy

                            Comment


                              #15
                              "Talk without the support of action means nothing..."
                              ― DaShanne Stokes

                              ***Unite(D) to Fight Paralyses***

                              Comment

                              Working...
                              X